Medicines Agency EUDRANET EudraGMP EudraPharm EudraVigilance EudraCT EudraCT Supporting Documentation EudraCT FAQ International Standard Randomised Controlled... 7 KB (530 words) - 14:23, 18 April 2024 |
drug reactions reports. Clinical trial Drug development EudraCT EudraGMP EudraLex EUDRANET EudraPharm European Clinical Research Infrastructures Network... 3 KB (233 words) - 13:05, 19 January 2024 |
GMP inspection.” European Medicines Agency EUDRANET EudraCT EudraPharm EudraVigilance GxP EudraGMP.EMA. 2007. Web November 13, 2013. http://eudragmdp... 3 KB (310 words) - 13:02, 19 January 2024 |
 | in 2008 to evaluate a product. Ethics Committee EudraCT EudraGMP EudraLex EUDRANET EudraPharm EudraVigilance European and Developing Countries Clinical... 38 KB (3,464 words) - 18:14, 27 March 2024 |
section at the EMEA. European Medicines Agency EUDRANET EudraCT EudraGMP EudraVigilance EudraPharm (in English) EUDRANET Projects of Common Interest for... 2 KB (161 words) - 02:42, 4 January 2024 |
 | mucocutaneous lesions is listed on ClinicalTrials.gov (NCT03073967) and EudraCT (2020-004940-27). Pritelivir is a member of the helicase-primase inhibitors... 10 KB (1,008 words) - 08:37, 26 February 2024 |
 | reported on January 10, 2024 that the Phase III ADORE clinical trial (EudraCT 2020-003376-40 / NCT05178810) of FAB122/TW001 in ALS did not meet the primary... 19 KB (1,610 words) - 19:13, 11 April 2024 |
nCoV-19". EU Clinical Trials Register. European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved... 318 KB (19,351 words) - 20:00, 21 April 2024 |
clinical registry is the RPCEC (Cuban Public Registry of Clinical Trials). EudraCT is a database of all clinical trials conducted in the European Union since... 10 KB (1,085 words) - 14:50, 18 April 2024 |
 | NCT02378480 for "Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)" at ClinicalTrials.gov "Paratek Announces that Omadacycline... 15 KB (1,266 words) - 13:05, 27 January 2024 |